Pacific Biosciences: Q2 Earnings Insights

Pacific Biosciences PACB reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Pacific Biosciences missed estimated earnings by 6.25%, reporting an EPS of $-0.34 versus an estimate of $-0.32.

Revenue was up $4.86 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 11.93% drop in the share price the next day.

Here's a look at Pacific Biosciences's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.31 -0.28 -0.22 -0.20
EPS Actual -0.37 -0.30 -0.23 -0.21
Revenue Estimate 32.82M 36.12M 33.23M 29.89M
Revenue Actual 33.17M 36.02M 34.89M 30.61M

To track all earnings releases for Pacific Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

PACB Logo
PACBPacific Biosciences of California Inc
$1.32-4.41%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
17.81
Growth
7.58
Quality
Not Available
Value
26.58
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...